ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding ProPhase Labs, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 39 | +18 |
| Shares | 1.54M | 175 | 1.96M | +421.9K (+27.4%) |
| Value | $10.8M | $1.00K | $24.9M | +$14.1M (+131.1%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held ProPhase Labs, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hillsdale Investment Management Inc. | 71,499 | $907.0K | 0.07% |
| Globeflex Capital L P | 56,175 | $712.0K | 0.17% |
| Marshall Wace, LLP | 35,122 | $446.0K | 0.00% |
| Virtu Financial LLC | 34,275 | $435.0K | 0.04% |
| Millennium Management LLC | 25,562 | $324.0K | 0.00% |
| Dimensional Fund Advisors LP | 23,021 | $292.0K | 0.00% |
| Acadian Asset Management LLC | 19,883 | $251.0K | 0.00% |
| Quadrature Capital Ltd | 19,487 | $246.0K | 0.01% |
| Jump Financial, LLC | 16,502 | $209.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 15,332 | $194.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 13,210 | $168.0K | 0.00% |
| Bridgeway Capital Management, LLC | 13,200 | $167.0K | 0.00% |
| Goldman Sachs Group Inc | 12,905 | $164.0K | 0.00% |
| Precision Wealth Strategies, LLC | 10,495 | $152.0K | 0.12% |
| Proequities, Inc. | 6,773 | $86.0K | 0.01% |
| Advisor Group Holdings, Inc. | 4,222 | $54.0K | 0.00% |
| Simplex Trading, LLC | 1,885 | $23.0K | 0.00% |
| Citigroup Inc | 720 | $9.00K | 0.00% |
| Benjamin F. Edwards & Company, Inc. | 500 | $6.00K | 0.00% |
| CoreCap Advisors, LLC | 100 | $1.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held ProPhase Labs, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 17,926 | $125.0K |
| Susquehanna International Group, LLP | 11,434 | $80.0K |
| Tower Research Capital LLC (TRC) | 1,140 | $8.00K |
Not filed for Q2 2022 yet (1)
Institutions that held ProPhase Labs, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Dixon Hughes Goodman Wealth Advisors LLC | 175 | $1.00K |